期刊文献+

细胞色素P450SNP与冠心病易感性关系的研究进展 被引量:2

Advances in the relationship between cytochrome P450 SNP and susceptibility to coronary heart disease
下载PDF
导出
摘要 冠心病是一种由遗传和环境共同作用引起的复杂性疾病。大量研究表明细胞色素P450(CYP)代谢物如环氧二十碳三烯酸(EETs)、20-羟基二十碳四烯酸(20-HETE)和性激素在维持心血管功能稳态中起重要作用。在体内,CYP2C19和CYP2J2可催化花生四烯酸代谢生成EETs;CYP4F2和CYP1A1是20-HETE生成的主要合成酶;CYP17A1和CYP19是性激素合成的重要酶。因此,上述CYP基因的多态性很有可能通过影响其代谢产物的生成进而影响冠心病的发生。本文对近5年CYP基因多态性与冠心病易感性关联研究作一综述,以期为冠心病个体化防治提供参考。 Coronary heart disease (CHD) is caused by genetic environmental interaction. Studies have shown that cytochrome P450 (CYP) metabolites such as epoxyeicosatrienoic acids (EETs), 20-hydroxy-eicosatetraenoic acid ( 20-HETE ) and sex hormones play important roles in maintaining cardiovascular homeostasis. In vivo, CYP2C19 and CYP2J2 catalyze the metabolism of arachidonic acid (AA) to EETs; CYP4F2 and CYP1A1 are the main synthetases of 20-HETE; CYP17A1 and CYP19 are important synthetases of sex hormones. Therefore, polymorphism of the above CYP genes is likely to affect the development of CHD by influencing the production of its metabolites. This article reviews the five years′advances in the relationship between cytochrome P450 SNP and susceptibility to coronary heart disease so as to provide referential ideas for the personalized treatment of CHD.
作者 彭秋菊 严华成 石磊 PENG Qiuju;YAN Huacheng;SHI Lei(Department of Pharmacy, Guangzhou General Hospital of Guangzhou Military Command, Guangzhou 510010, Guangdong, China;College of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, Guangdong , China)
出处 《中国临床药理学与治疗学》 CAS CSCD 2018年第4期477-480,共4页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 广东省重大科技专项(2013A022100035)
关键词 冠心病 基因多态性 细胞色素 P450 易感性 coronary heart disease polymorphism cytochrome P450 susceptibility
  • 相关文献

参考文献3

二级参考文献24

  • 1李刚,周兴文.新的冠心病危险因素[J].心血管病学进展,2005,26(3):266-271. 被引量:24
  • 2楚玉荣,楚智慧,朱颖钊.ApoE基因多态性与早发冠心病关系的研究[J].现代生物医学进展,2007,7(2):244-246. 被引量:5
  • 3ERCAN B,AYAZ L,GIEK D,et al.Role of CYP2C9 and CYP2C19 polymorphisms in patients with atherosclerosis[J].Cell Biochem Funct,2008,26:309-313.
  • 4TRENK D,HOCHHOLZER W,FROMM M F,et al.Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents[J].J Am Coll Cardiol,2008,51:1925-1934.
  • 5BIECHE I,NARJOZ C,ASSELAH T,et al.Reverse transcriptase-PCR quantfication of m RNA levels from cytochrome(CYP)1,CYP2and CYP3families in 22different human tissuses[J].Pharmacogenet Genomics,2007,17:731-742.
  • 6KRAL B G,BECKER D M,VAIDY D,et al.Severity of inducible myocardial ischemia predicts incident acute coronary syndromes in asymptomatic individuals with a family hospital of premature coronary artery[J].J Nucl Cardiol,2012,19:28-36.
  • 7Medhora M,Dhanasekaran A,Gruenloh SK,et al . Emerging mechanisms for growth and protection of the vasculature by cytochrome P450 derived products of arachidonic acid and other eicosanoids [J].Prostaglandins & Other Lipid Mediators,2007, 82(1):19-29.
  • 8Elbekai RH,Elkadi AO.Cytochrome P450 enzymes:central playersin cardiovascular health and disease [J].Pharmacol Ther,2006,112(2):564-587.
  • 9Fleming I,Busse R.Vascular cytochrome P450 in the regulationof renal function and vascular tone:EDHF,superoxide anionsand blood pressure [J].Nephrol Dial Transplant,2001,16(7):1309-1311.
  • 10Letonja M,Peterlin B,Bregar D,et al .Are the T/C polymorphismof the CYP17 gene and the tetranucleotide repeat (TTTA)polymorphismof the CYP19 gene genetic markers for premature coronaryartery disease in Caucasians? [J]. Folia Biol (Praha),2005,51(3):76-81.

共引文献11

同被引文献16

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部